Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Grafton gets regulatory green light to buy HSS Hire Ireland

(Sharecast News) - Grafton Group's €32m acquisition of HSS Hire Group's Irish business has received regulatory approval, it was confirmed on Thursday. In a brief statement, HSS said it welcomed a decision by the Competition and Consumer Protection Commission in Ireland to give the deal unconditional clearance.

The sale is now set to complete by the end of the month, it added.

Building materials distributor Grafton first agreed to buy HSS Hire Ireland in early April.

It plans to rebrand the business, which operates from four branches and four customer distribution centres, as part of Chadwicks, its existing Irish distribution business.

The sale was also part of a wider restructuring at HSS, first announced last year. The Aim-listed firm has already separated its HSS ProService and operations units into two standalone businesses, with the latter rebranded The Hire Service Company.

Grafton, meanwhile, is following a strategy of strengthening its position in existing and adjacent markets.

As at 0930 BST, shares in Grafton were up 1% at 1,004.8p, while HSS was largely flat at 6.98p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.